Gamma’s China grant
This article was originally published in The Tan Sheet
Gamma Pharmaceuticals announces the Western United States Agricultural Trade Association approved the Las Vegas-based firm for up to $300,000 in annual reimbursement for eligible marketing and promotional activities in China. The WUSATA Branded Program is a marketing expense reimbursement program that supports the promotion of U.S. brand name products in foreign markets. On May 15, Gamma commenced shipment of 8 tons of its products including Brilliant Choice Gelibites nutritional supplements. The firm says the reimbursement will contribute to making Gamma's brands household names in China...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.